chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt. called our office on 10-20-11 to report that a few days after vaccination on 10-8-11 (IPOL, Tdap, TWINRIX - given IM all left deltoid) she noticed a "tingly" sensation in her left side which seemed to focus in her left breast area (states feeling was similar to lactation sensation she had when she breastfed her children). States sensation began to work its way around her left side to her back and that it began to become very itchy and painful inside. States she scheduled appt. with her GYN who could find nothing specific to diagnose her with. She called our office today out of concern that it might be related to the vaccinations. Instructed to contact her family doctor and be evaluated and informed that we would report this through the VAERS system. (In addition she states her menses started on the 12th following her vaccinations on the 8th). States her symptoms have not really improved since the onset through today 10-20-11.
Pt had shot on 6/10/21 , pt developed chest pain/lung pain on 6/28 and also tachycardia rate into the 120s at times, pt's chest pain/lung pain improved with sitting upright and bending forward.  Pt came to primary care office on 6/29 and had evaluation by chest x-ray, and ekg done in office.  pts symptoms and ekg were confirmatory for pericarditis.
Generalized itching; Generalized body aches; Nausea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Generalized body aches), PRURITUS (Generalized itching) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced NAUSEA (Nausea). On 05-Mar-2021, the patient experienced PAIN (Generalized body aches). On 10-Mar-2021, the patient experienced PRURITUS (Generalized itching). At the time of the report, PAIN (Generalized body aches), PRURITUS (Generalized itching) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided   Reporter did not allow further contact
Bad headache day 2 thru day 7  but off and on by end of week
On the third day she had hives on her neck and red eyes and ears. In addition, she felt pretty achy as well.
has not received the second dose.; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 22nd August 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not know the lot number or expiration date. No additional information provided. The reporter consented to follow up. This case was linked with case US2021174382, reported by same reporter for different patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021174382:Same reporter
Small, itchy, red rash spots. 4-5 on chest area. Next day 6 spots also appeared on upper left thigh. Next few days spots appeared in a randomly spaced line along outer thigh to knee of right leg. Itchy. Not blistery. After 2 days of appearing each went flat and stayed on skin for 4 more days. On 3/25/2011 developed hives around upper back and down left arm. May be stress related but lasted several days. Very itchy. No blisters.
20min p/inject pt developed acute conjunctivitis, rhinitis, itching of feet & tight, sore throat;
Information has been received from a registered nurse referring to a patient of unknown age and gender. The patients concurrent condition and medical history were not reported. On 16-JUN-2015 the patient was vaccinated with an expired dose of ZOSTAVAX (strength, lot # and expiration date were unknown, 0.65 ml) subcutaneously. No adverse effects were reported. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age with penicillin allergy. On 13-OCT-2104, the patient was vaccinated with ZOSTAVAX vial, lot # K007548, expiry date 23-AUG-2015, 0.65 milliliter, subcutaneous in the left arm. Concomitant medications were not reported. ON an unknown date approximately in October 2014, the patient experienced redness, swelling, pain and warmth on her left arm at the injection site after receiving ZOSTAVAX. On an unknown date approximately in October 2014, vesicles started to develop at the injection site. No treatment was given for the events. No lab diagnostics were performed. The outcome of vesicles starting to develop at the injection site and redness, swelling , pain and warmth on her left arm at the injection was reported as not recovered. Causality assessment was not reported. Patient sought medical attention and came back to pharmacy. Product quality complaint was not reported. Additional information has been requested.
Per client, had severe joint pain and pain at site of injection following administration of vaccine; developed worsening muscle and joint pain, headache, and difficulty walking, abdominal pain/cramping, urinary incontinence x 1, some chills and sweating, no fever. Neuro exam showed mild (L) central facial weakness, (L) sided dysmetria and paresthesia of (L) upper and lower extremities. Being treated with SOLUMEDROL and BENADRYL, PT; closely monitoring client inpatient.
Fever (over 101), chills, shaking, sweating, severe pain in left arm, felt like every part of every joint and muscle hurt.
Sore at injection site; A spontaneous report (United States) was received from a 86-year-old female patient, who received  Moderna's covid 19 vaccine (mRNA-1273) and experienced sore at injection site.  The patient's medical history include back pain from which she was scheduled to receive radiation. No relevant concomitant medications were reported.    On 15-Jan-2021, prior to the onset of event, the patient received first dose of mRNA-1273 (Lot: not provided) intramuscular injection for prophylaxis of COVID-19 infection.  On 15-Jan-2021, the patient experienced sore at injection site.   No treatment information provided.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.  Outcome of the event, sore at injection site is resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
One day post vax, face became red and bumpy around nose. Redness became more extensive by 03/22/2001. Seen by MD and advised to treat with OTC steroid cream. Area became more red, bumpy and covered a larger area to include nose, cheek, and chin. Area was itchy and throbbing.
Patient is a 26 y.o. male who received the Moderna Covid-19 Vaccine, mRNA-1273 (PF) 100 mcg/0.5 mL IM Susp, Lot 003B21A on 3/26/2021. The patient experienced the following reaction(s) during the immediate  of observation: 1:00pm Patient c/o dizziness during observation period. Patient was treated/managed as follows:   1:00pm Patient taken to treatment area to lay down. VS BP 115/82, HR 56, RR 18, O2 sat 99% on room air. Patient reports "feeling better." Patient given educational material regarding vaccine and advised to continue to self-monitor per the CDC guidance. 1:15pm Patient escorted to door by RN
This spontaneous report as received from a medical assistant refers to a male patient of unknown age. The patient's pertinent medical history and drug reactions/allergies were not reported. Two months ago (approximately May 2015), the patient was vaccinated with GARDASIL (dose, frequency and route were not reported) and on 22-JUL-2015 the patient went to the office to received his second dose of HPV vaccine, but they would be administering GARDASIL 9 (dose, frequency, lot number and route were not provided) to complete the series. No adverse experience was reported. No product quality complaint (PQC) was involved. Additional information has been requested.
After injection, left arm injection site became swollen with erythema/heat. Area approx. 1 1/2" with slight pain. No fever. Treatment Motrin as needed, warm compresses to site as needed.  Increase in arm movement.
white substance that is floating inside that cannot be resuspended; This is a spontaneous report received from contactable reporter(s) (Pharmacist) from medical information team and product quality group.  A patient (no qualifiers provided) received pneumococcal 20-valent conjugate vaccine  (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Lot number: FJ2602, Expiration Date: 30Jun2023) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIQUID PRODUCT PHYSICAL ISSUE (non-serious), outcome "unknown", described as "white substance that is floating inside that cannot be resuspended".  Additional information: Reporter received a box of PREVNAR 20 on the day of reporting. The product has a white substance that is floating inside that cannot be resuspended. Reporter asked for a replacement. She has prefilled syringes and she was about to use it for a patient and she got a blup of white stuff floating and she wanted to resuspend it. She did not shake it, she was twisting it back and forth for about 20 minutes and there were still floating substances in the syringe.   Follow-up attempts are completed. No further information is expected.
went into afib at 2300 hrs.  self converted at approxi, 1330 the following day
Headache, flush/fever, chills, sweating, aching, feels like swallowing knives, nasuea. Exhausted. Note: felt sicker then when I had morning sickness with twins. Truly the sickest I've ever been. Almost like an extreme flu.
This spontaneous report as received from a pharmacist refers to a child of less than 12 years old (gender was not reported). Concurrent or medical conditions were not reported. On an unknown date, the patient received an improperly stored dose of VARIVAX (Merck) (dose, strength, route and lot number were not reported). No adverse effects reported. No product quality complaint ws reported. This is one of two reports received from the same source. Additional information has been requested.
Expired vaccine beyond amnufacturer expiry date administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine beyond amnufacturer expiry date administered) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine beyond amnufacturer expiry date administered). On 13-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine beyond amnufacturer expiry date administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication use was reported.  The reporter did not think that any of the patients were pregnant because of their age. The reporter also thinks that it was the second dose for all recipients but was not sure.
Numbness and tingling in arms and legs for an hour. This started about 30 mins after dose.
10MAR97 slept all day, T;11MAR97 cranky,T;12MAR97 T, cough;13MAR97 T, harsh cough;14MAR97 funny cough took to MD had viral pneumonia;pt better p/breathing tx;20MAR hands turned blue & grunt like breathing;croup 13APR97;airway shut;
after the second dose she had a cough a few months  after that/nothing was wrong with her after the second dose, and then she developed the cough./states there's was never anything really wrong with her, just had this cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (after the second dose she had a cough a few months  after that/nothing was wrong with her after the second dose, and then she developed the cough./states there's was never anything really wrong with her, just had this cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (after the second dose she had a cough a few months  after that/nothing was wrong with her after the second dose, and then she developed the cough./states there's was never anything really wrong with her, just had this cough). At the time of the report, COUGH (after the second dose she had a cough a few months  after that/nothing was wrong with her after the second dose, and then she developed the cough./states there's was never anything really wrong with her, just had this cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.         No Treatment information was provided. No concomitant medication was provided.   This case was linked to MOD-2021-395953, MOD-2021-396015 (Patient Link).   Reporter did not allow further contact
stiffness, heat  very sleepy, constant headaches. Was getting better then it became worse again.
Patient was given Pfizer COVID-19 vaccine at 1:40 PM, he stayed sitting until around 2:15 PM and then passed out upon starting to walk away
Arm with injection site swelled and turned dark red and hot to the touch. Stayed this way for 30 hours. It occurred to me it could be an allergy, so I chewed a children's Benadryl. Started going down within minutes. Had to continue Benadryl for another 24 hours. Then super itchy; still warmer than normal to touch.
swollen left neck, diagnosis of lymphadenopathy, fever 104 2 days later, hospitalized two times, surgery (incision and drain) 14 days later
GFR of 47; Temperature up to 99 point something for about 2 days.; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE INCREASED (Temperature up to 99 point something for about 2 days.) and GLOMERULAR FILTRATION RATE DECREASED (GFR of 47) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014F21A, 010M20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Sep-2021, the patient experienced BODY TEMPERATURE INCREASED (Temperature up to 99 point something for about 2 days.). On 24-Sep-2021, the patient experienced GLOMERULAR FILTRATION RATE DECREASED (GFR of 47). On 17-Sep-2021, BODY TEMPERATURE INCREASED (Temperature up to 99 point something for about 2 days.) had resolved. At the time of the report, GLOMERULAR FILTRATION RATE DECREASED (GFR of 47) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Glomerular filtration rate: 62 (Low) Low. On 15-Sep-2021, Body temperature: 99 (High) High. On 17-Sep-2021, Body temperature: 99 (High) High. On 24-Sep-2021, Glomerular filtration rate: 47 (Low) Low. On 12-Oct-2021, Glomerular filtration rate: 49 (Low) Low.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   She did not experience any symptoms after the first 2 doses was noted.  No concomitant medication was provided by the reporter.  No treatment information was provided by the reporter.
05/05/21  Heart palpitations  Tightness Nauseous Fever Swollen  05/06/21 High fever Tightness all over body Hands were tight and closed by itself No appetite Stomach bloated  Went to ER Nauseous  Swollen
The patient who is 8 years old was accidentally given Pfizer BioNtech COVID19 Vaccine 8/29/2021. The Vaccine is not approved for the aged group. This is the primary reason for the incident reporting. Patient only suffers pain on injection site and feeling tire per patient's parents,
Rapid heart rate, nausea, fever, chills, headache, entire body ache especially at injection site (right arm).
I had Janssen vaccine on 3/10. I had some fatigue after, and was doing well until several hours later, when I developed severe chest pain, shortness of breath, headache, and back pain. I went to ER, fever to 102.2F. EKG w sinus tachycardia, heart rate 153bpm, treated with IV fluids, tylenol and IV ativan with significant symptomatic improvement. Labs and CXR were normal. Since then, I have not had any more symptoms.
Was given the Pentacel, Pneumococcal conjugate and seasonal flu vaccines at around 10:15am.  That evening, he had persistent crying, twitching, involuntary body movements, restless sleep, and awakenings every 30-40 minutes throughout the night. The following two days, inconsolable crying continued persistently with now know cause; unusual for a baby who is easily consolable.
Patient came in on 8.6.23 to pick up medication. He wanted to let us know and showed me his arm. He said he developed a hematoma at the injection site which went down bust still had bruising that went down the arm. He was okay but wanted to let us know about the event.
Bitter taste in her mouth; Pain in the arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Bitter taste in her mouth) and VACCINATION SITE PAIN (Pain in the arm of the injection) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced DYSGEUSIA (Bitter taste in her mouth) and VACCINATION SITE PAIN (Pain in the arm of the injection). At the time of the report, DYSGEUSIA (Bitter taste in her mouth) and VACCINATION SITE PAIN (Pain in the arm of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported included blood thinner Treatment details included ice pack on injection arm.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Pt presented to the office for a booster vaccine. Pt presented a vaccine card from another entity. On the card it was verified that the pts last dose was 2+ months ago. Pt was given the Bivalent booster. After the pt left, the vaccine was documented and vaccines were reconciled in the chart, that it when it was presented that the pt had already received the Bivalent in October.
30 mins p/vax grandma brought pt back to clinic stating had devel a rash; generlaized body was administered MD contact; MD examined pt VS nl x 1 hr;
There were no reported adverse s/s.  This patient was COVID positive on 11/29/21, received Monoclonal Antibody infusion on 12/1/21 and was instructed that he had to wait 90 days to start the vaccination process. However on 12/26/21 he presented to our vaccine clinic and received the vaccine without informing staff that he had recently received the antibody infusion. He is not reporting any adverse reaction at this time.
shortness of breath Narrative:  Patient received first dose of Pfizer COVID19 vaccine on 3/29/21. No adverse effects reported. Patient underwent a previously scheduled EGD 3/31/21 and presented to PCP appointment 4/13/21. Per PCP, patient reported nausea after eating and intermittent abdominal pain. No indication that symptoms were related to COVID19 vaccine. Patient received second Pfizer COVID19 vaccine dose 4/19/21. Reported developing shortness of breath, nausea, dizziness, headaches, and feeling like her throat is closing. Patient was transported to ED, however left AMA while sitting in triage without further treatment. Vital signs and labs gathered WNL. Patient was called 1 hour later and per nursing note, reported she was hungry and left to get food. Reported she felt better after eating and was going home to rest. Was called again 6 hours after symptom onset and reported a lump in her throat but no difficulty swallowing or breathing, no wheezing, rash, or tongue swelling. Was instructed to return to ED if symptoms worsened and self administer OTC diphenhydramine 25mg. Per ED MD note, patient also with a history of anxiety which may have been a contributing factor.
Patient present to office for eval of swollen ankles beginning 5/3/07. Bloodwork showed mild anemia and abnormal coagulation panel. Patient further complained of swelling, numbness to Right feet and daily headaches. Negative Doppler studies x2 for clots in legs. Patient received Garadasil #2 & Tdap vaccine 4/24/07.  Patient had normal CBC in 2/07. Patient now seeing hematogolist. 6/27/07-records received for DOS 4/23-5/21/07-Bilateral ankle edema, foot pain headaches. HX running track. On 5/21/07-Edema resolved. Residual right foot numbness. No fever or swelling for 3 days. Antiphospholid syndrome. To see hem/onc for anemia.
DIARRHEA; CONGESTION; CHILLS; Right kidney pain; Pain at injection site; FEVER; HEADACHE; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Pain at injection site), PYREXIA (FEVER), HEADACHE (HEADACHE), CHILLS (CHILLS) and RENAL PAIN (Right kidney pain) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced INJECTION SITE PAIN (Pain at injection site), PYREXIA (FEVER) and HEADACHE (HEADACHE). On 11-Feb-2021, the patient experienced CHILLS (CHILLS) and RENAL PAIN (Right kidney pain). On 16-Feb-2021, the patient experienced DIARRHOEA (DIARRHEA) and NASAL CONGESTION (CONGESTION). At the time of the report, INJECTION SITE PAIN (Pain at injection site), PYREXIA (FEVER), HEADACHE (HEADACHE), CHILLS (CHILLS), RENAL PAIN (Right kidney pain), DIARRHOEA (DIARRHEA) and NASAL CONGESTION (CONGESTION) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment details included ibuprofen.